Bank Of Montreal Vanda Pharmaceuticals Inc. Transaction History

Bank Of Montreal

$197 Billion
Q2 2024

A detailed history of Bank Of Montreal transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Bank Of Montreal holds 56,861 shares of VNDA stock, worth $265,540. This represents 0.0% of its overall portfolio holdings.

Number of Shares

56,861

Holding current value

$265,540

% of portfolio

0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.91 - $6.5 $222,326 - $369,596	56,861 New	56,861 $321,000
Q2 2023 Aug 02, 2023	BUY	$5.9 - $6.95 $1.76 Million - $2.08 Million	298,581 New	298,581 $1.97 Million
Q1 2023 Jun 13, 2024	BUY	$6.18 - $7.99 $68,356 - $88,377	11,061 New	11,061 $75,000
Q2 2022 Aug 11, 2022	SELL	$9.31 - $11.84 $135,972 - $172,923	-14,605 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$10.84 - $16.55 $878 - $1,340	-81 Reduced 0.55%	14,605 $173,000
Q4 2021 Feb 11, 2022	SELL	$15.69 - $21.14 $10.9 Million - $14.7 Million	-696,777 Reduced 97.94%	14,686 $246,000
Q3 2021 Nov 12, 2021	SELL	$15.35 - $21.27 $50,608 - $70,127	-3,297 Reduced 0.46%	711,463 $12.3 Million
Q2 2021 Aug 12, 2021	BUY	$15.71 - $21.51 $11.2 Million - $15.4 Million	714,760 New	714,760 $14.9 Million

Others Institutions Holding VNDA

# of Institutions

156

Shares Held

45.1M

Call Options Held

136K

Put Options Held

220K

Black Rock Inc. New York, NY

8.14M
Shares

$38 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.11M
Shares

$19.2 Million
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

3.43M
Shares

$16 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.15M
Shares

$10.1 Million
1.49% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.01M
Shares

$9.4 Million
0.0% of portfolio

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $264M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account